<DOC>
	<DOCNO>NCT00576277</DOCNO>
	<brief_summary>The purpose study determine safety , tolerability pharmacokinetics AV411 single multiple dose patient chronic neuropathic pain due diabetes .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Preliminary Efficacy AV411 Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Diagnosis diabetic neuropathy complex regional pain syndrome least 6 month duration VAS score 4 cm high Screening No clinical abnormality laboratory urine analyse Electrocardiogram within normal limit Screening Negative pregnancy test Study Day 1 female subject childbearing potential On stable dos medication , analgesic others least 8 week prior study enrollment Willing use barrier contraceptive period study Known hypersensitivity AV411 component Conditions might affect drug absorption , metabolism excretion Untreated mental illness , current drug addiction abuse alcoholism Donated blood past 90 day poor peripheral venous access Platelets &lt; 100,000mm3 history thrombocytopenia Known suspect chronic liver disease GFR &lt; =90mL/min/1.73m2 ( CockcroftGault ) Female subject pregnant nursing mother Received investigational drug past 90 day Unable swallow large capsule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>